Pavella Therapeutics Inc. (PVLA)
Market Closed
17 Jul, 20:00
$
157. 24
+9.47
+6.4086%
$
1.77B Market Cap
- P/E Ratio
- Div Yield
258,100 Volume
- Eps
$ 147.77
Previous Close 
Want to track PVLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pavella Therapeutics Inc. (PVLA) Statistics
Valuation metrics
Market Cap 1.77B
Enterprise value 1.66B
Trailing P/E (ttm) -37.71
Forward P/E -
PEG ratio -0.41
Price/Sales (ttm) -
Price/Book (mrq) 8.86
Enterprise Value/Revenue -
Enterprise Value/EBITDA -45.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 255.58K
Average volume (90 days) 251.56K
Price summary
52-Week low 28.19
52-Week high 161.38
Beta -
50-Day moving average 134.73
200-Day moving average 112.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:80
Last split Date 23 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.19%
Return on equity -0.57%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 20.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 28.88%
Book value per share (mrq) 17.75
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
